Transcriptomics

Dataset Information

0

Gene expression of monocytes from rheumatoid arthritis patients treated with bDMARDs and methotrexate.


ABSTRACT: It is well documented that patients affected by rheumatoid arthritis (RA) have distinct susceptibility to the different biologic Disease-Modifying AntiRheumatic Drugs (bDMARDs) available on the market, probably because of the many facets of the disease. Monocytes are deeply involved in the pathogenesis of RA and we therefore evaluated and compared the transcriptomic profile of monocytes isolated from patients on treatment with methotrexate alone or in combination with tocilizumab, anti-TNFalpha or abatacept, and from healthy donors. Differential expression analysis of whole-genome transcriptomics yielded a list of regulated genes suitable for functional annotation enrichment analysis. Specifically, abatacept, tocilizumab and anti-TNFalpha cohorts were separately compared with methotrexate using a rank-product-based statistical approach, leading to the identification of 78, 6, and 436 differentially expressed genes, respectively.

ORGANISM(S): Homo sapiens

PROVIDER: GSE224330 | GEO | 2023/03/09

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-08-23 | GSE172188 | GEO
2013-12-30 | E-GEOD-45867 | biostudies-arrayexpress
2013-12-30 | GSE45867 | GEO
2017-05-17 | E-GEOD-68215 | biostudies-arrayexpress
2016-07-21 | E-GEOD-78068 | biostudies-arrayexpress
2017-05-17 | GSE68215 | GEO
2020-07-24 | GSE91079 | GEO
2020-02-07 | GSE135770 | GEO
2008-09-20 | GSE12860 | GEO
2008-10-25 | E-GEOD-12860 | biostudies-arrayexpress